Convex Clinical Research Center with Phase I Unit is a leading Contract Research Organization (CRO) located in Eastern Europe, specifically in Bulgaria. With over 30 years of experience, Convex CRO offers a comprehensive range of clinical research services to support the development of investigational drugs and medical devices for small to mid-size pharmaceutical, biotechnology, generics, vaccines, and nutrition companies. As a full-service CRO, Convex CRO handles every aspect of the clinical trial process, from feasibility assessment to final report development.

Their services include medical writing, regulatory activities, subject recruitment, clinical monitoring, data management, biostatistics, and much more. With a network of over 72 investigational sites, including hospitals and private medical institutions, Convex CRO has extensive experience in conducting multicenter clinical trials in various therapeutic areas. In addition, Convex Clinical Research Center has a state-of-the-art Phase I Unit dedicated to conducting early-phase clinical trials.

This unit is equipped to perform a wide range of studies, including first-in-man studies, phase I clinical studies, pharmacokinetic and pharmacodynamic studies, bioequivalence and bioavailability studies, and safety and efficacy studies. The unit can accommodate 15 subjects for overnight stays and provides all necessary facilities for storing study drugs, managing biological samples, and handling emergency situations. With their expertise and commitment to excellence, Convex Clinical Research Center is the ideal partner for companies looking to advance their medicinal products through clinical research